BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/12/2026 6:27:04 AM | Browse: 1 | Download: 0
 |
Received |
|
2026-07-24 06:42 |
|
Peer-Review Started |
|
2026-07-28 00:02 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2026-08-03 02:34 |
|
Revised |
|
2026-08-06 10:57 |
|
Publication Fee Transferred |
|
2026-08-19 05:21 |
|
Second Decision by Editor |
|
2026-09-10 00:14 |
|
Second Decision by Editor-in-Chief |
|
2026-09-10 18:42 |
|
Final Decision by Editorial Office Director |
|
2026-09-18 10:41 |
|
Articles in Press |
|
2026-09-18 10:41 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-09-24 00:40 |
|
Publish the Manuscript Online |
|
2026-10-12 06:27 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, General & Internal |
| Manuscript Type |
Case Report |
| Article Title |
Maturity-onset diabetes of the young type 6 in China and the utility of semaglutide: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Gui-Yan Chen, Liu-Xue Yang, Zhui Chen, Zhi-Qing Liang and Lin-Hua Pi |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Guangxi Natural Science Foundation |
No. 2026GXNSFAA00640444 and No. 2025GXNSFHA069136 |
|
| Corresponding Author |
Lin-Hua Pi, MD, PhD, Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Guilin Medical University, No. 212 Renming Road, Guilin 541004, Guangxi Zhuang Autonomous Region, China. 18126970199@163.com |
| Key Words |
Maturity-onset diabetes of the young; Neurogenic differentiation 1 gene; Glucagon-like peptide-1 receptor agonist; Semaglutide; Case report |
| Core Tip |
Maturity-onset diabetes of the young type (MOD) 6, as a subtype of MODY caused by mutations in the neurogenic differentiation 1 gene, has been poorly reported, and its clinical features and treatments remain unclear. We report the case of a young man with MODY6 who was affected a mutation p.Asp331Glu in the neurogenic differentiation 1 gene and effectively and safely treated with semaglutide, which led to significant improvements in glycemic management and weight loss. |
| Publish Date |
2026-10-12 06:27 |
| Citation |
Chen GY, Yang LX, Chen Z, Liang ZQ, Pi LH. Maturity-onset diabetes of the young type 6 in China and the utility of semaglutide: A case report. World J Diabetes 2026; 17(10): 126085
|
| URL |
https://www.wjgnet.com/1948-9358/full/v17/i10/126085.htm |
| DOI |
https://doi.org/10.4239/wjd.126085 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
